Today's corporate announcements include significant leadership news, with Wessex Water appointing a new CFO. On the innovation front, Thalia Therapeutics detailed its RNA therapeutic strategy for cardiovascular disease, while BSF Enterprise unveiled a technical white paper on its AI-reconstructed T-Rex Leather, expanding into sustainable material science. Operationally, Quantum Helium provided an update on its Sagebrush-1 well, confirming helium potential through ongoing production tests. Additionally, GCP Asset Backed Income advanced its capital return strategy by selling a care home loan portfolio for over £41 million, and Everyman Media Group saw an Executive Director increase his stake, signaling insider confidence.
Wessex Water Services announced a significant leadership transition with the retirement of its Chief Financial Officer, Andy Pymer, after more than three decades with the company. Richard Eadie, currently Anglian Water Services' Executive Finance Director, will take over as CFO in August. Eadie brings 13 years of senior finance experience within the UK water sector, having previously held various finance and strategy roles at Severn Trent Water. The board thanked Pymer for his leadership and contribution during his 14 years on the executive board.
Biotechnology firm Thalia Therapeutics THAT released a new video interview featuring its Chief Executive Officer, Dr. David Solomon. In the interview, Dr. Solomon discussed the company's strategy for developing differentiated next-generation RNA therapeutics, highlighting the significant innovation potential in the expanding market. He specifically detailed Thalia's approach to cardiovascular disease, which involves a preclinical candidate designed to address two independent risk factors, PCSK9 and Lp(a), concurrently for enhanced therapeutic benefits. This update provides insight into the company's strategic direction and innovative pipeline.
Biotech platform company BSF Enterprise BSFA announced its subsidiary, Lab-Grown Leather, has published a comprehensive technical white paper on its proprietary "T-Rex Leather™" product line. The document outlines the engineering biology, structural performance, and luxury market potential of this innovative bio-material. The project began by isolating T. rex collagen fragments, which were then reconstructed using advanced AI-powered protein modeling to create a new version called Gen4-3. This development showcases BSF's platform technology scaling into disruptive, zero-waste premium materials beyond its initial medical applications.
Everyman Media Group EMAN announced that its Interim Creative Director and Executive Director, Charles Dorfman, purchased additional shares in the company. Between May 29 and June 1, Dorfman acquired 7,750 Ordinary Shares at 35.85 pence and 15,300 Ordinary Shares at 36 pence per share. Following these transactions, his direct interest now stands at 6,311,809 Ordinary Shares, representing 6.90 percent of the company's issued share capital. This executive director's share purchase signals a degree of confidence in the company's performance.
Quantum Helium QHE provided an operational update on the ongoing extended production test at its Sagebrush-1 well in Colorado, USA. The company announced the successful completion of an initial acid injection programme on the upper Leadville zone. Technical analysis from this activity supports advancing to the next phase of reservoir stimulation, involving planned fracture stimulation to enhance reservoir connectivity. Preliminary analysis also confirmed that the raw gas produced bears close similarities to historical gas analysis conducted in 1994, suggesting positive indications for the helium-bearing formation's commercial potential.
GCP Asset Backed Income Fund GABI announced it has exchanged contracts for the sale of a portfolio comprising three senior loans. These loans are secured against operational care home projects located in the UK, with the disposal valued at a minimum of £41.4 million, aligning with their most recently published net asset value. The transaction is expected to complete mid-June. This move aligns with the company's investment policy to manage the realization of its loan portfolio and return capital to shareholders, with a fourth compulsory redemption anticipated alongside the June 2026 net asset value publication.